Bicycle Health Highlights Underserved Opioid Treatment Market During Awareness Week

According to a recent LinkedIn post from Bicycle Health, the company is using National Drug and Alcohol Facts Week to highlight treatment gaps in opioid use disorder care. The post cites 2022 data indicating that about 4% of U.S. adults needed treatment for opioid use disorder, while only 25% of those received recommended medications.

The post suggests that this gap is driven not only by capacity constraints but also by stigma, misinformation, and systemic barriers to evidence-based care. By emphasizing opioid use disorder as a chronic, treatable condition, Bicycle Health appears to be positioning its model around education, early intervention, and access to proven medication-based treatment.

For investors, the message underscores a sizeable, underserved market where demand for effective treatment is likely to remain structurally high. If Bicycle Health can convert awareness efforts into patient acquisition and payer partnerships, this environment could support long-term growth, though regulatory scrutiny, reimbursement dynamics, and competition across digital and in-person addiction treatment providers remain key risks.